Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

Share Price is delayed by 15 minutes
Get Live Data
381.00    8.00 (2.14%)
Bid:
379.00
Ask:
400.00
Spread: 21.00 (5.541%)
Market Cap: £152.30m
DIA Live PriceLast checked at - London Stock Exchange

Intraday Dialight Share Chart

Directorate Change

2 Aug 2021 07:00

RNS Number : 1572H
Dialight PLC
02 August 2021
 

 

 

 

 

Dialight plc ("Dialight" or the "Group")

 

Board role changes

 

 

Dialight plc (LSE: DIA.L), the global leader in LED lighting for heavy industrial applications, today announces changes in the Board chair and other Board roles that will all take effect on 10 September 2021.

 

Chair

 

David Blood has indicated to the Board that it is an appropriate time for him to step down as Chair, following two years in the role. The Board has accepted his decision and wishes to place on record its gratitude to him for his significant contribution in the role. David will remain on the Board as a non-executive director of Dialight.

 

Following an externally facilitated review, the Board has asked Karen Oliver to take on the position of Chair and she has accepted. Karen has been a non-executive director of Dialight since 1 April 2020 and has extensive experience across a range of industrial sectors. Karen will also assume the role of chair of the Nominations Committee. The Board considers Karen to be independent upon her appointment as Board chair.

 

Senior Independent Director

 

Dialight has previously announced that Stephen Bird will step down as a director and as the Board's Senior Independent Director as he nears 9 years on the Board. David Thomas will become the Board's Senior Independent Director in addition to his continuing role as chair of the Audit Committee

 

Other changes

 

Gaelle Hotellier will assume responsibility as the workforce engagement non-executive director alongside her existing duties as chair of the Remuneration Committee.

 

Gotthard Haug will be appointed to the Audit Committee.

 

David Blood commented:

"The past two years have been a period of great change at Dialight, yet also a time for stabilisation. I am greatly encouraged to see the continuing improvement in the Group's performance. I am pleased to be able to hand over to Karen and for her, and Fariyal, to guide the Group through its next phase of growth. I will remain on the Board and fully engaged, confident that the leadership of the Group is in good hands."

 

Karen Oliver commented:

"I am really excited to take on the position of Chair and work closely with Fariyal and the board of directors to implement the next phase of our growth strategy and create sustainable value for our shareholders and customers. I am very impressed with the commitment of the Dialight team and their achievements during the challenges of Covid-19, and believe the progress over the past two years has put Dialight in a strong position to capitalise on the transition to LED lighting and benefit from further growth opportunities in LED electronic components."

 

 

There are no further matters to be disclosed pursuant to Rule 9.6.13 of the Listing Rules.

 

This announcement contains inside information for the purposes of article 7 of EU Regulation 596/2014

 

The person responsible for arranging release of this announcement on behalf of Dialight plc is Richard Allan, General Counsel and Company Secretary of Dialight plc.

 

Contact:

Richard Allan

General Counsel and Company Secretary

Tel: +44 (0) 7740 882 227

 

About Dialight:

Dialight (LSE: DIA.L) is a global leader in sustainable LED lighting for industrial applications. Dialight's LED products are providing the next generation of lighting solutions that deliver reduced energy consumption and create a safer working environment. Our products are specifically designed to provide superior operational performance, reliability and durability, reducing energy consumption and ongoing maintenance and achieving a rapid return on investment. The company is headquartered in the UK, with operations in the Australia, Dubai, Germany, Malaysia, Mexico, Singapore, UK and USA. To find out more about Dialight, visit www.dialight.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPBMATMTBMBMB
Date   Source Headline
2nd Jun 20267:00 amRNSNotice of Results & Investor Presentation
28th May 20267:00 amRNSHolding(s) in Company
26th May 20267:00 amRNSHolding(s) in Company
13th May 202612:52 pmRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights and Admission of Shares
1st Apr 20269:54 amRNSTransaction in Own Shares
30th Mar 20263:43 pmRNSDirector/PDMR Shareholding
25th Mar 20269:32 amRNSDirector/PDMR Shareholding
16th Mar 202610:41 amRNSIssue of Equity and Total Voting Rights
16th Mar 202610:41 amRNSIssue of Equity and Total Voting Rights
26th Feb 20266:32 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSThird Quarter Trading Update
12th Nov 20259:33 amRNSInvestor Presentation via Investor Meet Company
11th Nov 20254:55 pmRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSFY26 Interim Results
6th Oct 20257:00 amRNSTrading Statement
30th Sep 20257:00 amRNSBlock listing Interim Review
16th Sep 20259:39 amRNSTotal Voting Rights
3rd Sep 20251:24 pmRNSHolding(s) in Company
2nd Sep 20253:34 pmRNSResult of AGM - Addendum
1st Sep 20253:21 pmRNSResult of AGM
1st Sep 20257:00 amRNSTrading Statement
14th Aug 20251:05 pmRNSHolding(s) in Company
11th Aug 202512:58 pmRNSHolding(s) in Company
1st Aug 20255:57 pmRNSHolding(s) in Company
1st Aug 20255:54 pmRNSHolding(s) in Company
1st Aug 20255:47 pmRNSHolding(s) in Company
1st Aug 20251:33 pmRNSHolding(s) in Company
14th Jul 20252:04 pmRNSNotice of AGM
14th Jul 202510:05 amRNSAnnual Financial Report
4th Jul 20257:00 amRNSDirector/PDMR Shareholding
3rd Jul 202510:18 amRNSDirector/PDMR Shareholding
24th Jun 202512:53 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
1st May 20254:04 pmRNSDirectorate Change
7th Apr 20254:50 pmRNSTotal Voting Rights
7th Apr 20254:44 pmRNSBlock listing Interim Review
31st Mar 20257:00 amRNSSanmina Final Agreement, Trading update
20th Mar 20255:49 pmRNSApplication for Block Listing
20th Mar 20257:00 amRNSDirector Declaration
19th Mar 20253:37 pmRNSDirector/PDMR Shareholding
18th Mar 20255:17 pmRNSDirector/PDMR Shareholding
14th Mar 20252:42 pmRNSHolding(s) in Company
4th Feb 20257:30 amRNSDirector Declaration
4th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSTrading Statement
10th Dec 20247:00 amRNSDirectorate Change
25th Nov 20247:00 amRNSHalf-year Report
11th Nov 20247:00 amRNSDirectorate Change
4th Nov 20242:03 pmRNSDate of half-year results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.